A Masters student at the University of Waikato, New Zealand plans to use 3D printed models to grow breast cancer tumours outside the body and use them to test treatments. Shalini Guleria also plans to test the effectiveness of breast cancer drug Cisplatin on the bio-printed tumours. As the bioprinted tumor mesh grows, Guleria plans to observe the rate at which it increases in a 3D model when compared with a 2D model. Her long-term goal is to use the 3D printing technology to develop patient-specific cells. The research was funded by a grant from the National Institute for Health Research (NIHR) in Australia.
A Masters student at the University of Waikato, New Zealand plans to use 3D printed models to grow breast cancer tumours outside the body and use them to test treatments. Shalini Guleria also plans to test the effectiveness of breast cancer drug Cisplatin on the bio-printed tumours. Her long-term goal is to use the 3D printing technology to develop patient-specific cells. The research was funded by a grant from the National Institute for Health Research (NIHR) in Australia.